Thyroid dysfunction in rheumatoid arthritis: a controlled prospective survey.
…, M Cohen, ML Ballachey, C Neville - Annals of the rheumatic …, 1993 - ard.bmj.com
OBJECTIVES--To determine whether thyroid dysfunction is found with increased frequency
in patients with rheumatoid arthritis (RA). METHODS--A controlled prospective survey was …
in patients with rheumatoid arthritis (RA). METHODS--A controlled prospective survey was …
Low‐dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis. Results of a multicenter randomized, double‐blind, placebo …
JB Shiroky, C Neville, JM Esdaile… - … : Official Journal of …, 1993 - Wiley Online Library
Objective. To determine whether the side effects of methotrexate can be decreased by the
concurrent use of leucovorin, without affecting the efficacy of the methotrexate. Methods. We …
concurrent use of leucovorin, without affecting the efficacy of the methotrexate. Methods. We …
Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus?
…, PR Fortin, L Pilote, C Neville… - Arthritis Care & …, 2008 - Wiley Online Library
Objective Systemic lupus erythematosus (SLE) is characterized by a markedly elevated risk
for coronary heart disease (CHD), the exact pathogenesis of which is unknown. In particular, …
for coronary heart disease (CHD), the exact pathogenesis of which is unknown. In particular, …
Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity.
C Neville, AE Clarke, L Joseph, P Belisle… - The Journal of …, 2000 - europepmc.org
Objective Differences have been described between patient and physician assessments of
well being in several chronic illnesses, and these differences may affect outcome. …
well being in several chronic illnesses, and these differences may affect outcome. …
Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies
C Neville, J Rauch, J Kassis, ER Chang… - Thrombosis and …, 2003 - thieme-connect.com
Asymptomatic antiphospholipid antibody (aPL) carriers with high risk for thrombosis may
benefit from preventive anticoagulation. It was our objective to test whether the risk of …
benefit from preventive anticoagulation. It was our objective to test whether the risk of …
Discordance between patients and their physicians in the assessment of lupus disease activity: relevance for clinical trials
JC Yen, C Neville, PR Fortin - Lupus, 1999 - journals.sagepub.com
Discordance between patient and physician assessment of lupus activity occurs frequently
and its determinants are not known. Examples of discordance between patients and …
and its determinants are not known. Examples of discordance between patients and …
The needs of patients with arthritis: the patient's perspective
C Neville, PR Fortin, MA Fitzcharles… - Arthritis Care & …, 1999 - Wiley Online Library
Objective To identify concerns and learning interests of patients with arthritis. Methods A
questionnaire was developed, pilot tested, and then used to evaluate 197 patients with arthritis, …
questionnaire was developed, pilot tested, and then used to evaluate 197 patients with arthritis, …
Risk for incident arterial or venous vascular events varies over the course of systemic lupus erythematosus.
ER Chang, CA Pineau, S Bernatsky, C Neville… - The Journal of …, 2006 - jrheum.org
OBJECTIVE: We describe the pattern of incidence of thrombovascular events after diagnosis
of systemic lupus erythematosus (SLE) in a cohort of lupus patients. METHODS: Descriptive …
of systemic lupus erythematosus (SLE) in a cohort of lupus patients. METHODS: Descriptive …
Antiphospholipid antibodies predict imminent vascular events independently from other risk factors in a prospective cohort
C Neville, J Rauch, J Kassis… - Thrombosis and …, 2009 - thieme-connect.com
Antiphospholipid antibodies (aPL) are associated with vascular events, but the magnitude
of this risk, alone, or in combination with other atherogenic and thrombophilic risk factors, …
of this risk, alone, or in combination with other atherogenic and thrombophilic risk factors, …
Do lupus disease activity measures detect clinically important change?
…, M Abrahamowicz, AE Clarke, C Neville… - The Journal of …, 2000 - europepmc.org
Objective New scales for the clinical assessment of patients with systemic lupus
erythematosus (SLE) are valid and reliable, and quantitate disease activity. We assessed the …
erythematosus (SLE) are valid and reliable, and quantitate disease activity. We assessed the …